Monthly rates of <i>Clostridium difficile</i> by reporting mode.

<p>Monthly rates of <i>Clostridium difficile</i> by reporting mode.</p

Factors associated with concordant Clostridium difficile diagnosis by positive <i>Clostridium difficile</i> toxin assay (CDTA+) and ICD-9 code (ICD9+).

<p>Factors associated with concordant Clostridium difficile diagnosis by positive <i>Clostridium difficile</i> toxin assay (CDTA+) and ICD-9 code (ICD9+).</p

Flowchart of <i>Clostridium difficile</i> diagnoses among all patients admitted in 2007 to Tan Tock Seng Hospital.

<p>Flowchart of <i>Clostridium difficile</i> diagnoses among all patients admitted in 2007 to Tan Tock Seng Hospital.</p

Factors associated with concordant Clostridium difficile diagnosis by positive <i>Clostridium difficile</i> toxin assay (CDTA+) and ICD-9 code (ICD9+).

<p>Factors associated with concordant Clostridium difficile diagnosis by positive <i>Clostridium difficile</i> toxin assay (CDTA+) and ICD-9 code (ICD9+).</p

Cumulative incident of toxicity and treatment failure in the first treatment

<p><b>Copyright information:</b></p><p>Taken from "Impact of drug classes and treatment availability on the rate of antiretroviral treatment change in the TREAT Asia HIV Observational Database (TAHOD)"</p><p>http://www.aidsrestherapy.com/content/4/1/18</p><p>AIDS Research and Therapy 2007;4():18-18.</p><p>Published online 17 Sep 2007</p><p>PMCID:PMC2048495.</p><p></p> x axis is "years". Y axis is "cumulative incidence". green line represents toxicity failure. red line represents treatment failure [see Figure 2

Cox proportional hazards models of time until first viral failure after entry.

<p>Cox proportional hazards models of time until first viral failure after entry.</p

Patient characteristics.

<p>cART - combination antiretroviral therapy.</p><p>HIC - High Income Countries.</p><p>M/LIC - Middle/Low Income Countries.</p><p>ADI - AIDS Defining Illnesses.</p><p>HCV - Hepatitis C Virus.</p><p>HBV - Hepatitis B Virus.</p

Place of exposure and place of diagnosis (arrows) of GeoSentinel Zika patients from Africa (green dot), Asia (red dots), and the Pacific (blue dots)—Circular arrows indicate cases in international travelers who contracted Zika while abroad and were diagnosed in the country of exposure while traveling.

<p>Linear arrows indicate cases in international travelers who contracted Zika while abroad and had their diagnosis confirmed on returning to their home country.—Base map is available free of charge from <a href="http://www.histgeo.ac-aix-marseille.fr/ancien_site/carto/" target="_blank">http://www.histgeo.ac-aix-marseille.fr/ancien_site/carto/</a>.</p

Temporal association of endemic and exported cases with travel notices by international authorities for selected countries in Africa.

<p>Temporal association of endemic and exported cases with travel notices by international authorities for selected countries in Africa.</p

Demographic, itinerary, and laboratory characteristics of GeoSentinel Zika patients from Africa, Asia, and the Pacific.

<p>Demographic, itinerary, and laboratory characteristics of GeoSentinel Zika patients from Africa, Asia, and the Pacific.</p